CN101401865A - Chinese medicine composition for curing gout - Google Patents
Chinese medicine composition for curing gout Download PDFInfo
- Publication number
- CN101401865A CN101401865A CNA2008101586912A CN200810158691A CN101401865A CN 101401865 A CN101401865 A CN 101401865A CN A2008101586912 A CNA2008101586912 A CN A2008101586912A CN 200810158691 A CN200810158691 A CN 200810158691A CN 101401865 A CN101401865 A CN 101401865A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- medicine composition
- gout
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 201000005569 Gout Diseases 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 22
- 241000255789 Bombyx mori Species 0.000 claims abstract description 11
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 238000011282 treatment Methods 0.000 claims description 25
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 10
- 210000004369 blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 230000017531 blood circulation Effects 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 6
- 230000008961 swelling Effects 0.000 abstract description 5
- 208000024891 symptom Diseases 0.000 abstract description 5
- 244000148659 Acanthopanax sieboldianus Species 0.000 abstract 1
- 235000015559 Acanthopanax sieboldianus Nutrition 0.000 abstract 1
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 240000006432 Carica papaya Species 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 241000972672 Phellodendron Species 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010018634 Gouty Arthritis Diseases 0.000 description 2
- 201000001431 Hyperuricemia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 2
- 229960003459 allopurinol Drugs 0.000 description 2
- 238000005267 amalgamation Methods 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 210000001255 hallux Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 208000027744 congestion Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 210000004417 patella Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229960004618 prednisone Drugs 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 1
- 229960003081 probenecid Drugs 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating gout, which consists of the following raw medicines by weight: 5-15 grams of achyranthes root, 10-20 grams of wu chia pee, 10-20 grams of Chinese atractylodes, 10-20 grams of phellodendron, 10-15 grams of silkworm excrement, 5-15 grams of papaya, 10-20 grams of red sage root, 10-20 grams of white peony roots and 10-20 grams of ramulus mori. The traditional Chinese medicine composition for treating gout has the advantages that the composition can promote blood circulation, reduce blood viscosity and rapidly relieve ache, rigor, swelling, stiff flexion-extension and other symptoms of stiff limbs activities, and has no side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of gout, belong to the field of Chinese medicines.
Background technology
Along with improving constantly of people's living standard, the dietary structure imbalance causes purine metabolic disturbance, causes that blood uric acid increases, and the urate crystal of needle point size is deposited on positions such as joint, soft tissue, kidney, forms goat.The gout course of disease is many decades, and has the intermittently characteristics of outbreak.The cause of gout is a hyperuricemia, and the reason by hyperuricemia forms can be divided into gout constitutional and Secondary cases two classes.Primary gout accounts for the overwhelming majority, is about more than 90%, and certain familial inheritance tendency is arranged.
Conventional medicament can only temporarily be controlled the gout disease mostly after heavy dose of medication, but can not thoroughly eradicate.Tracing it to its cause is the only treatments of starting with of the uric acid from single reduction blood of these conventional medicaments, will be and really eradicate gout by falling acid, acid discharge, and the acid-base balance that comprehensively promotes health.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition for the treatment of gout, but blood circulation promoting, reduce blood viscosity, remove the disadvantageous symptoms of limb activity such as pain and stiff, swelling, joint stuffiness rapidly.
The technical scheme that the present invention deals with problems is:
A kind of Chinese medicine composition for the treatment of gout, it is characterized in that it is made up of the crude drug of following weight: Radix Achyranthis Bidentatae 5-15g, Cortex Acanthopancis 10-20g, Rhizoma Atractylodis 10-20g, Cortex Phellodendri 10-20g, Bombyx mori L. 10-15g, Fructus Chaenomelis 5-15g, Radix Salviae Miltiorrhizae 10-20g, Radix Paeoniae Alba 10-20g, Ramulus Mori 10-20g.
A kind of Chinese medicine composition for the treatment of gout provided by the invention is characterized in that, the preferred following composition of its crude drug:
Radix Achyranthis Bidentatae 10g, Cortex Acanthopancis 15g, Rhizoma Atractylodis 15g, Cortex Phellodendri 15g, Bombyx mori L. 12g, Fructus Chaenomelis 10g, Radix Salviae Miltiorrhizae 15g, Radix Paeoniae Alba 15g, Ramulus Mori 15g.
A kind of Chinese medicine composition for the treatment of gout provided by the invention, its preparation and instructions of taking are:
Earlier said components was soaked in water 2 hours, decocting in water 30 minutes is poured out medicinal liquid; Again medicinal residues are added decocting in water 30 minutes, pour out medicinal liquid; Twice medicinal liquid amalgamation rises, and little fire distills the part of anhydrating, and promptly gets the Chinese medicine composition of this kind treatment gout.One after each meal, day clothes potion, potion is taken at twice.Serveing on 20 days is a course of treatment.
Modern medicine is thought: human body forms goat because blood uric acid increases, and the urate crystal of needle point size is deposited on positions such as joint, soft tissue, kidney.The traditional Chinese medical science thinks that its etiology and pathogenesis is: the gout sharp ache, and outbreak repeatedly, and multiple complications is arranged, so be different from general arthromyodynia again.The many strongly fragrant heat-transformation of a specified duration of heresy or internal injury deficiency of the liver and kindey or the blood stasis stagnation of phlegm and cause by damp and hot heresy of diseases caused by exogenous pathogenic factor or wind and cold of primary disease.At the etiology and pathogenesis of primary disease, we are with Radix Achyranthis Bidentatae, Cortex Acanthopancis, Rhizoma Atractylodis, Cortex Phellodendri, Bombyx mori L., Fructus Chaenomelis, Radix Salviae Miltiorrhizae, all medicine compatibilities of the Radix Paeoniae Alba, the effect of playing promoting blood circulation by removing wind, removing obstruction in the collateral to relieve pain altogether.
The pharmacological action of a kind of its each raw material of Chinese medicine composition for the treatment of gout provided by the invention is as follows:
Radix Achyranthis Bidentatae: sweetness and bitterness acid, flat; Go into liver, kidney channel.Give birth to and use dissipating blood stasis blood, subduing inflammation.Control gonorrhea, hematuria, amenorrhea ， mass in the abdomen, difficult labour, retention of placenta, postnatal blood stasis stomachache, sore throat, carbuncle, traumatic injury.Ripely use invigorating the liver and kidney, bone and muscle strengthening.Control waist kneecap pain, spasm of the limbs, flaccidity syndrome and arthralgia syndrome.
Cortex Acanthopancis: wind-damp dispelling, strengthening bone and muscle, blood circulation and promoting silt.Control anemofrigid-damp arthralgia, the muscles and bones contraction is anxious, lumbago, sexual impotence, skin ulcer cellulitis toxic swelling, traumatic injury impairment caused by overstrain.
Rhizoma Atractylodis: arduous, temperature; Go into spleen, stomach warp.Spleen invigorating, dampness, resolving depression is warded off dirty.Control wet the Sheng and be stranded spleen, the asthenia drowsiness, gastral cavity painful abdominal mass abdominal distention, inappetence, vomiting is had loose bowels, dysentery, malaria, phlegm retention, edema, seasonal epidemic pathogens flu, anemofrigid-damp arthralgia, flaccidity of the lower limbs, nyctalopia.
Cortex Phellodendri: hardship, cold; Go into kidney, urinary bladder channel.Heat clearing away, dampness, pathogenic fire purging removes steams, and skin ulcer is treated in detoxifcation.Be used for damp-heat dysentery, jaundice, leukorrhagia, pyretic stranguria, osteopyrexia and fever, night sweat, seminal emission, sore swollen toxin, eczema pruritus.
Bombyx mori L.: Gan Xin, temperature; Go into liver, spleen channel.Expelling wind and removing dampness, the analgesic therapy of invigorating blood circulation.The dispelling the wind and dampness pathogens arthralgia pain, the rubella pruritus, the wind syndrome of head headache, munbness, the joint is unsuccessful, the convulsion of sharply vomiting and diarrhoea, waist foot cold type of pain, marginal blepharitis eye.
Fructus Chaenomelis: acid, temperature; Go into liver, spleen channel.Suppressing the hyperactive liver and easing the stomach, Shujin dries.Control the convulsion of vomiting and diarrhoea, arthralgia chiefly caused by damp pathogen, beriberi, edema, dysentery.
Radix Salviae Miltiorrhizae: hardship is slightly cold; GUIXIN, Liver Channel.Activating blood circulation to dissipate blood stasis, the removing heat from blood mind calming.This product is fallen and promoting the circulation of blood, is apt to into blood system, can qualcomm meridian, change stasis, clearing away heart-fire, removing heat from blood heat, and the will of calming the nerves, remove and throb with fear tiredly, be usually used in obstruction of qi in the chest and cardialgia, menstruation portion transfers, skin infection swells and ache, insomnia and congestion disease such as swell and ache.
The Radix Paeoniae Alba: picric acid, cold; Go into liver, spleen channel.Nourishing blood to suppress the hyperactive liver, slow middle pain relieving, yin fluid astringing is received antiperspirant. control the breast abdomen pain over the hypochondriac region, spontaneous sweating, fever due to yin deficiency.Ramulus Mori: hardship, flat.Go into Liver Channel.Wind-damp dispelling, sharp joint, row aqueous vapor.Control anemofrigid-damp arthralgia, spasm of the limbs, beriberi edema, human body pruritus due to wind pathogen.
A kind of Chinese medicine composition for the treatment of gout provided by the invention has characteristics such as short treating period, rapid-action, treating both the principal and secondary aspects of a disease, cure rate height.But blood circulation promoting, reduce blood viscosity, remove the disadvantageous symptoms of limb activity such as pain and stiff, swelling, joint stuffiness rapidly, without any side effects.The model case of treatment has:
Case one: cover so-and-so, man, 57 years old.Gout 7 years.The extremity multi-joint is lasting outbreak.Often take colchicine, allopurinol, probenecid, prednisone etc.Once used dexamethasone.The local joint hormone blockade, check: right sufficient big toe arthroncus, tenderness is obvious, right instep redness.Be diagnosed as gout.Take course of treatment of Chinese medicine composition of this kind treatment goat, right instep redness disappears, and continues treatment 3 months, and symptom is all eliminated, and follows up a case by regular visits to not recurrence in 3 years.
Case two: Liu so-and-so, man, 46 years old.Gouty arthritis 5 years, redness and swelling of joints are shown effect frequently bitterly, recurrence in about 1 month 1 time, and companion's lower limb are heavy, diagnosis: gouty arthritis.Liver function injury appears in allopurinol 0.3-0.6/d. commonly used, stops Western medicine voluntarily and uses the Chinese medicine naturopathy instead.Through taking Drug therapy of the present invention after two courses of treatment, clinical symptoms disappears, and two big toe joint pigments change light.After after treatment half a year.Routine blood test, and hepatic and renal function all normal, follow up a case by regular visits to 2 years so far arthritis and do not recur.
The specific embodiment
Embodiment 1
Make a kind of Chinese medicine composition for the treatment of gout by the crude drug of following weight:
Radix Achyranthis Bidentatae 10g, Cortex Acanthopancis 15g, Rhizoma Atractylodis 15g, Cortex Phellodendri 15g, Bombyx mori L. 12g, Fructus Chaenomelis 10g, Radix Salviae Miltiorrhizae 15g, Radix Paeoniae Alba 15g, Ramulus Mori 15g.
Its preparation and using method are:
Earlier said components was soaked in water 2 hours, decocting in water 30 minutes is poured out medicinal liquid; Again medicinal residues are added decocting in water 30 minutes, pour out medicinal liquid; Twice medicinal liquid amalgamation rises, and little fire distills the part of anhydrating, and promptly gets the Chinese medicine composition of this kind treatment gout.One after each meal, day clothes potion, potion is taken at twice.Serveing on 20 days is a course of treatment.
Embodiment 2
Make a kind of Chinese medicine composition for the treatment of gout by the crude drug of following weight:
Radix Achyranthis Bidentatae 10g, Cortex Acanthopancis 10g, Rhizoma Atractylodis 12g, Cortex Phellodendri 12g, Bombyx mori L. 12g, Fructus Chaenomelis 12g, Radix Salviae Miltiorrhizae 15g, Radix Paeoniae Alba 15g, Ramulus Mori 15g.
Its preparation and using method: with embodiment 1.
Embodiment 3
Make a kind of Chinese medicine composition for the treatment of gout by the crude drug of following weight:
Radix Achyranthis Bidentatae 15g, Cortex Acanthopancis 15g, Rhizoma Atractylodis 15g, Cortex Phellodendri 20g, Bombyx mori L. 10g, Fructus Chaenomelis 10g, Radix Salviae Miltiorrhizae 20g, Radix Paeoniae Alba 15g, Ramulus Mori 15g.
Its preparation and using method: with embodiment 1.
Embodiment 4
Make a kind of Chinese medicine composition for the treatment of gout by the crude drug of following weight:
Radix Achyranthis Bidentatae 12g, Cortex Acanthopancis 15g, Rhizoma Atractylodis 15g, Cortex Phellodendri 12g, Bombyx mori L. 12g, Fructus Chaenomelis 10g, Radix Salviae Miltiorrhizae 15g, Radix Paeoniae Alba 12g, Ramulus Mori 12g.
Its preparation and using method: with embodiment 1.
Claims (2)
1, a kind of Chinese medicine composition for the treatment of gout, it is characterized in that it is made up of the crude drug of following weight: Radix Achyranthis Bidentatae 5-15g, Cortex Acanthopancis 10-20g, Rhizoma Atractylodis 10-20g, Cortex Phellodendri 10-20g, Bombyx mori L. 10-15g, Fructus Chaenomelis 5-15g, Radix Salviae Miltiorrhizae 10-20g, Radix Paeoniae Alba 10-20g, Ramulus Mori 10-20g.
2, according to the Chinese medicine composition of the described treatment gout of claim 1, it is characterized in that it is made up of the crude drug of following weight: Radix Achyranthis Bidentatae 10g, Cortex Acanthopancis 15g, Rhizoma Atractylodis 15g, Cortex Phellodendri 15g, Bombyx mori L. 12g, Fructus Chaenomelis 10g, Radix Salviae Miltiorrhizae 15g, Radix Paeoniae Alba 15g, Ramulus Mori 15g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101586912A CN101401865B (en) | 2008-11-10 | 2008-11-10 | Traditional Chinese medicine composition for treating gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101586912A CN101401865B (en) | 2008-11-10 | 2008-11-10 | Traditional Chinese medicine composition for treating gout |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101401865A true CN101401865A (en) | 2009-04-08 |
| CN101401865B CN101401865B (en) | 2012-05-23 |
Family
ID=40536114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101586912A Expired - Fee Related CN101401865B (en) | 2008-11-10 | 2008-11-10 | Traditional Chinese medicine composition for treating gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101401865B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102908451A (en) * | 2012-11-13 | 2013-02-06 | 毕振冬 | Traditional Chinese medicine composition for treating gout |
| CN105688096A (en) * | 2016-04-18 | 2016-06-22 | 姜凤霞 | Traditional Chinese medicine composition for treating gout |
| CN106309848A (en) * | 2016-11-01 | 2017-01-11 | 山东省中医药研究院 | Traditional Chinese medicine compound for treating gout and preparation method thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100425268C (en) * | 2005-11-15 | 2008-10-15 | 李乃荣 | Medicament for treating gout |
-
2008
- 2008-11-10 CN CN2008101586912A patent/CN101401865B/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102908451A (en) * | 2012-11-13 | 2013-02-06 | 毕振冬 | Traditional Chinese medicine composition for treating gout |
| CN105688096A (en) * | 2016-04-18 | 2016-06-22 | 姜凤霞 | Traditional Chinese medicine composition for treating gout |
| CN106309848A (en) * | 2016-11-01 | 2017-01-11 | 山东省中医药研究院 | Traditional Chinese medicine compound for treating gout and preparation method thereof |
| CN106309848B (en) * | 2016-11-01 | 2019-05-21 | 山东省中医药研究院 | A kind of Chinese medicine composition and preparation method thereof for treating gout |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101401865B (en) | 2012-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102671054B (en) | Traditional Chinese medicine composition for treating thrombophlebitis | |
| CN104740458A (en) | Pruritus treating traditional Chinese medicine composition | |
| CN101953926B (en) | Oral Chinese medicinal composition for treating gout | |
| CN101670058B (en) | Traditional Chinese medicine composition for treating gout | |
| CN103933167B (en) | A kind of Chinese medicine for the treatment of urticaria | |
| CN101401865B (en) | Traditional Chinese medicine composition for treating gout | |
| CN102614487A (en) | Plaster for treatment of prostate and uracratia | |
| CN104873851A (en) | Internal and external traditional-Chinese-medicine composition for treating bedsore | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN102579750B (en) | Traditional Chinese medicine composition for treating primary dysmenorrhea | |
| CN104383479A (en) | Traditional Chinese medicine foot bath composition for treating varicosity and preparation method of traditional Chinese medicine foot bath composition | |
| CN104107393A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN103041085B (en) | Traditional Chinese medicine composition for treating dysmenorrheal by lavipeditum nursing and application | |
| CN101028503B (en) | Oral Chinese-medicine composition for treating Raynaud's disease | |
| CN105267415A (en) | Traditional Chinese medicine composition for treating osteomyelitis | |
| CN105663408A (en) | Decoction medicine for treating abnormal menstruation and insufficient menstrual blood volume as well as preparation method thereof | |
| CN104055900A (en) | Traditional Chinese medicine composition for treating urticaria | |
| CN103961490A (en) | Compound medicine for treating wind-cold-dampness arthralgia and preparation method thereof | |
| CN103933388B (en) | A kind of traditional Chinese medicine preparation for treating pregnancy edema | |
| CN103751467A (en) | Traditional Chinese medicine composition for treating lumbar and back myofascitis and preparation method thereof | |
| CN104013718A (en) | Field thistle decoction traditional Chinese medicine preparation | |
| CN105664129A (en) | Traditional Chinese medicine composition for treating gout | |
| CN105343707A (en) | Traditional Chinese medicine used for treating erythema annulare centrifugum | |
| CN103127352B (en) | Chinese medicine composition for treating blood stasis type irregular menstruation | |
| CN105560610A (en) | Traditional Chinese medicine for treating bone fracture and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: FENG HUI Free format text: FORMER OWNER: ZHENG LEI Effective date: 20120229 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250200 JINAN, SHANDONG PROVINCE TO: 252000 LIAOCHENG, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20120229 Address after: 252000 Third People's Hospital of Chiping County, 150 Xin Gong Road, Chiping, Shandong, Liaocheng Applicant after: Feng Hui Address before: No. 50 Municipal Science and Technology Bureau of Ji'nan city of Shandong province Huiquan road 250200 Zhangqiu Mingshui Applicant before: Zheng Lei |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CI01 | Publication of corrected invention patent application |
Correction item: Inventor Name Correct: Feng Hui False: Zheng Lei Number: 21 Volume: 28 |
|
| CI03 | Correction of invention patent |
Correction item: Inventor Name Correct: Feng Hui False: Zheng Lei Number: 21 Page: The title page Volume: 28 |
|
| ERR | Gazette correction |
Free format text: CORRECT: INVENTOR NAME; FROM: ZHENG LEI TO: FENG HUI |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120523 Termination date: 20121110 |